Recent research highlights the role of sensory nerves in promoting breast cancer metastasis. By secreting neuropeptides, these nerves enhance tumor growth and spread, revealing a potential new therapeutic target. The study shows that the FDA-approved drug aprepitant can inhibit this pathway, reducing metastasis in breast cancer models. This breakthrough underscores the critical link between the nervous system and cancer, offering new avenues for treatment.
Recent research highlights the role of sensory nerves in promoting breast cancer metastasis. By secreting neuropeptides, these nerves enhance tumor growth and spread, revealing a potential new therapeutic target. The study shows that the FDA-approved drug aprepitant can inhibit this pathway, reducing metastasis in breast cancer models. This breakthrough underscores the critical link between the nervous system and cancer, offering new avenues for treatment.
Share this Article
Recommended